{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T04:06:27Z","timestamp":1791173187093,"version":"4.1.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,1,16]],"date-time":"2018-01-16T00:00:00Z","timestamp":1516060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Health Econ Rev"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13561-018-0185-7","type":"journal-article","created":{"date-parts":[[2018,1,16]],"date-time":"2018-01-16T02:30:56Z","timestamp":1516069856000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["The relationship between target joints and direct resource use in severe haemophilia"],"prefix":"10.1186","volume":"8","author":[{"given":"Jamie","family":"O\u2019Hara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaun","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4250-4218","authenticated-orcid":false,"given":"Charlotte","family":"Camp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Mazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liz","family":"Carroll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Hoxer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Wilkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,1,16]]},"reference":[{"key":"185_CR1","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/1750-1172-7-97","volume":"7","author":"A Liras","year":"2012","unstructured":"Liras A, Segovia C, Gab\u00e1n AS. Advanced therapies for the treatment of hemophilia: future perspectives. Orphanet J. Rare Dis. 2012;7:97.","journal-title":"Orphanet J. Rare Dis."},{"key":"185_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2516.2012.02909.x","volume":"19","author":"A Srivastava","year":"2013","unstructured":"Srivastava A, Brewer AK, Mauser-Bunschoten EP, Key NS, Kitchen S, Llinas A, et al. WFH guidelines: guidelines for the management of hemophilia. Haemophilia. 2013;19:1\u201347.","journal-title":"Haemophilia"},{"key":"185_CR3","doi-asserted-by":"publisher","first-page":"207","DOI":"10.2147\/JBM.S50644","volume":"5","author":"S Lobet","year":"2014","unstructured":"Lobet S, Hermans C, Lambert C. Optimal management of hemophilic arthropathy and hematomas. J Blood Med Dove Press. 2014;5:207\u201318.","journal-title":"J Blood Med Dove Press"},{"issue":"Suppl 4","key":"185_CR4","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1111\/j.1365-2516.2004.00976.x","volume":"10","author":"K Mulder","year":"2004","unstructured":"Mulder K, Llin\u00e1s A. The target joint. Haemophilia. 2004;10(Suppl 4):152\u20136.","journal-title":"Haemophilia"},{"key":"185_CR5","doi-asserted-by":"publisher","first-page":"2368","DOI":"10.1182\/blood-2016-02-683169","volume":"129","author":"MJ Manco-Johnson","year":"2017","unstructured":"Manco-Johnson MJ, Soucie JM, Gill JC. Prophylaxis usage, bleeding rates and joint outcomes of hemophilia 1999 - 2010: a surveillance project. Blood. 2017;129:2368\u201375.","journal-title":"Blood"},{"key":"185_CR6","doi-asserted-by":"publisher","first-page":"S360","DOI":"10.1016\/j.amepre.2011.09.017","volume":"41","author":"PE Monahan","year":"2011","unstructured":"Monahan PE, Baker JR, Riske B, Soucie JM. Physical functioning in boys with hemophilia in the U.S. Am J Prev Med. 2011;41:S360\u20138.","journal-title":"Am J Prev Med"},{"key":"185_CR7","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1111\/hae.12108","volume":"19","author":"M Bladen","year":"2013","unstructured":"Bladen M, Main E, Hubert N, Koutoumanou E, Liesner R, Khair K. Factors affecting the Haemophilia joint health score in children with severe haemophilia. Haemophilia. 2013;19:626\u201331.","journal-title":"Haemophilia"},{"key":"185_CR8","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1111\/j.1365-2516.2010.02400.x","volume":"17","author":"JM Soucie","year":"2011","unstructured":"Soucie JM, Wang C, Siddiqi A, Kulkarni R, Recht M, Konkle BA, et al. The longitudinal effect of body adiposity on joint mobility in young males with Haemophilia a. Haemophilia. 2011;17:196\u2013203.","journal-title":"Haemophilia"},{"key":"185_CR9","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1111\/j.1365-2516.2012.02863.x","volume":"18","author":"M Iannone","year":"2012","unstructured":"Iannone M, Pennick L, Tom A, Cui H, Gilbert M, Weihs K, et al. Prevalence of depression in adults with haemophilia. Haemophilia. 2012;18:868\u201374.","journal-title":"Haemophilia"},{"key":"185_CR10","doi-asserted-by":"publisher","first-page":"e101","DOI":"10.1111\/j.1365-2516.2011.02683.x","volume":"18","author":"FRMY Cassis","year":"2012","unstructured":"Cassis FRMY, Querol F, Forsyth A, Iorio A, HERO International Advisory. Board. Psychosocial aspects of haemophilia: a systematic review of methodologies and findings. Haemophilia. 2012;18:e101\u201314.","journal-title":"Haemophilia"},{"key":"185_CR11","unstructured":"World Federation of Hemophilia. Frequently asked questions about hemophilia [Internet]. 2012 [cited 2015 Jul 31]. Available from: \n                    http:\/\/www.wfh.org\/en\/page.aspx?pid=637#Life_expectancy\n                    \n                  ."},{"key":"185_CR12","first-page":"413","volume":"2011","author":"KA Johnson","year":"2011","unstructured":"Johnson KA, Zhou Z-Y. Costs of care in hemophilia and possible implications of health care reform. Hematology am. Soc. Hematol. Educ. Program. 2011;2011:413\u20138.","journal-title":"Program"},{"key":"185_CR13","first-page":"10","volume":"22","author":"S Henrard","year":"2012","unstructured":"Henrard S, Hermans C, Devleesschauwer B, Speybroeck N. Oral presentations: abstracts. Eur J Public Health O. 2012;22:10\u2013125.","journal-title":"Eur J Public Health O"},{"key":"185_CR14","unstructured":"Kodra Y, Cavazza M, Schieppati A, De Santis M, Armeni P, Arcieri R, et al. The social burden and quality of life of patients with haemophilia in Italy. Blood Transfus. SIMTI Servizi; 2014;12 Suppl 3:s567\u2013s575."},{"issue":"1","key":"185_CR15","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s13023-017-0660-y","volume":"12","author":"J O\u2019Hara","year":"2017","unstructured":"O\u2019Hara J, Hughes D, Camp C, Burke T, Carroll L. Diego D-AG. The cost of severe haemophilia in Europe: the CHESS study. Orphanet J Rare Dis. 2017;12(1):106.","journal-title":"Orphanet J Rare Dis"},{"key":"185_CR16","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1046\/j.1365-2516.2003.00849.x","volume":"10","author":"RLRL Bohn","year":"2004","unstructured":"Bohn RLRL, Aledort LM, Putnam K, Ewenstein B, Mogun H, Avorn JJ. The economic impact of factor VIII inhibitors in patients with haemophilia. Haemophilia. 2004;10:63\u20138.","journal-title":"Haemophilia"},{"issue":"Suppl 1","key":"185_CR17","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/j.1365-2516.2005.01153.x","volume":"11","author":"C Knight","year":"2005","unstructured":"Knight C. Health economics of treating haemophilia a with inhibitors. Haemophilia. 2005;11(Suppl 1):11\u20137.","journal-title":"Haemophilia"},{"key":"185_CR18","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1111\/j.1538-7836.2007.02663.x","volume":"5","author":"BA Konkle","year":"2007","unstructured":"Konkle BA, Ebbesen LS, Erhardtsen E, Bianco RP, Lissitchkov T, Rusen L, et al. Randomized, prospective clinical trial of recombinant factor VIIa for secondary prophylaxis in hemophilia patients with inhibitors. J Thromb Haemost Blackwell Publishing Ltd. 2007;5:1904\u201313.","journal-title":"J Thromb Haemost Blackwell Publishing Ltd"},{"key":"185_CR19","doi-asserted-by":"crossref","unstructured":"Glick HA, Doshi JA, Sonnad SS, Polsky D. Economic Evaluation in Clinical Trials. Oxford University Press; 2014.","DOI":"10.1093\/med\/9780199685028.001.0001"},{"key":"185_CR20","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1002\/hec.1653","volume":"20","author":"B Mihaylova","year":"2011","unstructured":"Mihaylova B, Briggs A, O\u2019Hagan A, Thompson SG. Review of statistical methods for analysing healthcare resources and costs. Health Econ. 2011;20:897\u2013916.","journal-title":"Health Econ"},{"key":"185_CR21","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.jval.2013.10.004","volume":"17","author":"D Coughlan","year":"2014","unstructured":"Coughlan D, Yeh ST, Neill CO, Frick KD. Evaluating direct medical expenditures estimation methods of adults using the medical expenditure panel survey : an example focusing on head and neck cancer. Value Heal Elsevier. 2014;17:90\u20137.","journal-title":"Value Heal Elsevier"},{"key":"185_CR22","unstructured":"Stata Statistical Software. College Station: StataCorp; 2013."},{"key":"185_CR23","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1111\/jth.12672","volume":"12","author":"VS Blanchette","year":"2014","unstructured":"Blanchette VS, Key NS, Ljung LR, Manco-Johnson MJ, van den Berg HM, Srivastava A, et al. Definitions in hemophilia: communication from the SSC of the ISTH. J Thromb Haemost. 2014;12:1935\u20139.","journal-title":"J Thromb Haemost"},{"key":"185_CR24","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1093\/pch\/12.5.381","volume":"12","author":"VE Price","year":"2007","unstructured":"Price VE, Hawes SA, Chan AK. A practical approach to hemophilia care in children. Paediatr Child Heal. 2007;12:381\u20133.","journal-title":"Paediatr Child Heal"},{"key":"185_CR25","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1111\/j.1365-2516.2006.01202.x","volume":"12","author":"S Donadel-Claeyssens","year":"2006","unstructured":"Donadel-Claeyssens S. European Paediatric network for Haemophilia management. Current co-ordinated activities of the PEDNET (European Paediatric network for Haemophilia management). Haemophilia. 2006;12:124\u20137.","journal-title":"Haemophilia"},{"key":"185_CR26","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1111\/hae.13201","volume":"23","author":"J Hanley","year":"2017","unstructured":"Hanley J, McKernan A, Creagh MD, Classey S, McLaughlin P, Goddard N, et al. Guidelines for the management of acute joint bleeds and chronic synovitis in haemophilia: a United Kingdom Haemophilia Centre doctors\u2019 organisation (UKHCDO) guideline. Haemophilia. 2017;23:511\u201320.","journal-title":"Haemophilia"}],"container-title":["Health Economics Review"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13561-018-0185-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13561-018-0185-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13561-018-0185-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,20]],"date-time":"2019-09-20T23:39:41Z","timestamp":1569022781000},"score":1,"resource":{"primary":{"URL":"https:\/\/healtheconomicsreview.biomedcentral.com\/articles\/10.1186\/s13561-018-0185-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,16]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["185"],"URL":"https:\/\/doi.org\/10.1186\/s13561-018-0185-7","relation":{},"ISSN":["2191-1991"],"issn-type":[{"value":"2191-1991","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,16]]},"assertion":[{"value":"25 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"LW and CH are employees of Novo Nordisk.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"1"}}